← Eichor
Condition: Hypercortisolism Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hypercortisolism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Steroids-Based Screening for Primary Aldosteronism
Phase N/A · 1 location(s) · Qifu Li · NCT06941116
Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
Phase N/A · 1 location(s) · First Affiliated Hospital of Chengdu Medical College · NCT06228677
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06773663
Evaluation of Adults With Endocrine and Metabolic-Related Conditions
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02830308
Pathological Type,Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
Phase N/A · 1 location(s) · Qifu Li · NCT06597630
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
NA · 1 location(s) · University Hospital, Toulouse · NCT07470580
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
Phase N/A · 1 location(s) · Shanghai 6th People's Hospital · NCT07156370
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
NA · 2 location(s) · Seoul National University Hospital · NCT07027254
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Phase 1/Phase 2 · 1 location(s) · Crinetics Pharmaceuticals Inc. · NCT05804669
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · 60 location(s) · Sparrow Pharmaceuticals · NCT07296484
The Effect of SAAE on Vascular Endothelial Function in PA Patients
Phase N/A · 1 location(s) · Second Affiliated Hospital of Nanchang University · NCT05561361
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Phase N/A · 50 location(s) · Zhujiang Hospital · NCT05638269
Diagnosing Variable Primary Aldosteronism.
Phase N/A · 1 location(s) · Queen Mary University of London · NCT05765786
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
NA · 1 location(s) · Haukeland University Hospital · NCT05368090
Primary Aldosteronism in Western Norway
Phase N/A · 2 location(s) · Haukeland University Hospital · NCT02832388
Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
NA · 3 location(s) · Göteborg University · NCT05797558
Overnight Dexamethasone in Primary Aldosteronism Screening
Phase N/A · 1 location(s) · Medical University of Gdansk · NCT06740838
Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spect
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT07635134
Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism
Phase 2 · 1 location(s) · University of Calgary · NCT05472493
Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Phase N/A · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT07703683
A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
NA · 1 location(s) · Zhe Meng · NCT06250699
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · 51 location(s) · Duke University · NCT04278404
Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hyperco
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05911620
Biomarkers and Choroidal Neovascularization
Phase N/A · 2 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04439708
Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06750172
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Witho
Phase N/A · 1 location(s) · Qifu Li · NCT06955286
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrom
Phase 2 · 15 location(s) · RECORDATI GROUP · NCT03708900
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2 · 1 location(s) · Mayo Clinic · NCT07104812
Non Invasive Imaging Methods for Detecting PA:a Clinical PET Study of 18F-Pentixather
NA · 1 location(s) · Fangfang Sun · NCT06581744
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.